GlassScriptPhysician profile
Kaitlin E Zeedyk
NPI 1912331281
$4,456.88
in general payments reported to CMS, 2019-2025
49 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $315 · 2022: $1,360 · 2023: $1,546 · 2024: $675 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,781.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $627.01 | 2021-2025 | |
| Stryker Corporation | $523.87 | 2023-2024 | Mako, Gmrs, Triathlon |
| Acera Surgical, INC. | $430.70 | 2022-2025 | Restrata Wound Matrix |
| Daiichi Sankyo INC. | $242.02 | 2022-2023 | Enhertu |
| Zimmer Biomet Holdings, INC. | $195.94 | 2023 | Rosa |
| Seagen INC. | $167.44 | 2021-2023 | Tukysa |
| Astrazeneca Pharmaceuticals LP | $158.83 | 2021-2024 | Lynparza, Imfinzi |
| Davol INC. | $156.69 | 2022 | |
| Integra Lifesciences Corporation | $138.31 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mirati Therapeutics, INC. | $137.48 | 2023-2024 | Krazati |
| Astellas Pharma US INC | $134.06 | 2021-2025 | Xospata, Vyloy |
| Eisai INC. | $108.86 | 2022-2024 | |
| Amgen INC. | $101.60 | 2021-2023 | Xgeva, Nplate, Lumakras |
| Takeda Pharmaceuticals U.S.A., INC. | $101.19 | 2022-2023 | Vpriv |
| Regeneron Healthcare Solutions, INC. | $87.84 | 2021-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $86.76 | 2021-2023 | Jakafi |
| Onkos Surgical, INC. | $84.34 | 2023 | Eleos Limb Salvage System |
| Karyopharm Therapeutics INC. | $75.46 | 2022-2023 | Xpovio |
| Lilly USA, LLC | $67.72 | 2022-2023 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $57.94 | 2021-2022 | |
| Genzyme Corporation | $48.82 | 2021-2025 | |
| Becton, Dickinson and Company | $44.93 | 2024 | Channel Drain |
| Abbvie INC. | $44.48 | 2021-2022 | |
| Ucb, INC. | $42.99 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $41.96 | 2021 | |
| Kci USA, INC. | $39.68 | 2023 | Activ.A.C. Ion Progress, Prevena, Snap |
| Bayer Healthcare Pharmaceuticals INC. | $38.22 | 2022-2023 | |
| Urgo Medical North America, LLC | $35.01 | 2025 | Urgok2 |
| Boston Scientific Corporation | $32.60 | 2025 | Watchman Flx |
| Tersera Therapeutics LLC | $30.78 | 2022-2023 | Zoladex |
| Taiho Oncology, INC. | $30.36 | 2022-2023 | |
| Pharmacyclics LLC, An Abbvie Company | $29.55 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $26.22 | 2022 | |
| Orthofix Medical, INC. | $25.86 | 2024 | Physio-Stim |
| Tactile Systems Technology INC | $25.48 | 2024 | Entre Plus, Flexitouch Plus |
| Dynasplint Systems INC. | $23.12 | 2025 | Dynasplint |
| Ethicon US, LLC | $22.50 | 2025 | Surgicel Nu-Knit, Vistaseal, Evarrest |
| Jazz Pharmaceuticals INC. | $19.09 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $19.00 | 2025 | Sancuso |
| Genmab U.S., INC. | $18.07 | 2022 | |
| Blueprint Medicines Corporation | $18.03 | 2023 | Ayvakit |
| Stemline Therapeutics INC. | $17.27 | 2025 | Elzonris |
| Solventum Corporation | $16.47 | 2025 | Prevena |
| Pfizer INC. | $15.00 | 2022 | |
| Glaxosmithkline, LLC. | $14.77 | 2023 | Shingrix |
| Morphosys, US INC. | $14.27 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $14.00 | 2025 | |
| Genentech USA, INC. | $13.12 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Zeedyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.